Facebook Linkedin Twitter
Inside Precision Medicine FDA Authorizes First DTC Cancer Risk Test, 23andMe’s GRH Report for BRCA1 and BRCA2 Mutations

Ovarian cancer

Patient having a mouth swab test
Molecular Dx

FDA Authorizes First DTC Cancer Risk Test, 23andMe’s GRH Report for BRCA1 and BRCA2 Mutations

0
Micrograph of ovarian dysgerminoma
Molecular Dx

AZ to Use Myriad’s myChoice HRD Plus Test in Phase III Trial

0
Ironman-Boxes-PGM-Dx-30Apr2017
Molecular Dx

CMS Proposes Coverage for Thermo Fisher Scientific NSCLC Diagnostic

Alex Philippidis
0
Detection of Ovarian Cancer Recurrence: Quality Control Routines using an Integrated Proteomics Approach
News & Features

Detection of Ovarian Cancer Recurrence: Quality Control Routines using an Integrated Proteomics Approach

0
Genetics of Neurodegenerative Disorders – How Mutations Affect Disease Pathology
News & Features

Genetics of Neurodegenerative Disorders – How Mutations Affect Disease Pathology

0
Two Young Women at a Breast Cancer Awareness Rally
News & Features

Racial Disparities of Cancer-Causing Mutations Addressed in New Study

0
Clinical OMICs Magazine: Volume 3
News & Features

Clinical OMICs Magazine Volume 3, Issue No. 3

0
Source: David Wong
Molecular Dx

Liquid Biopsy Thrusts Non-Invasive Molecular Diagnostics into the Clinical Arena

Jeffrey S. Buguliskis, Ph.D.
0
Source: iStock/© AlexRaths
News & Features

Color Genomics Launches Benefits Program for Breast, Ovarian Cancer Risk Testing

0
More Ovarian Cancer Detected if Biomarker Velocities Are Scrutinized
News & Features

More Ovarian Cancer Detected if Biomarker Velocities Are Scrutinized

0
1...91011Page 10 of 11

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine